Yeji
FDA approvalconf 0.90

risto-cel — FDA approval

$BEAM · Beam Therapeutics Inc.
Event date
Date TBD
Sponsor runway
28 mo
$1.21B liquid

Evidence

“a potential additional $100 million draw at the Company's option upon the FDA's approval of the risto-cel BLA prior to a certain date”
Source: 8-K filed 2026-02-24View on EDGAR ↗0001193125-26-065191

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

6 insiders · 0 buys · 7 sells
Sell10b5-1
2026-04-01
Ciaramella Giuseppe
President
11,810 @ $24.58$290K
Sell10b5-1
2026-04-01
Cavanagh Bethany J
SVP, Finance and Treasurer
3,242 @ $24.58$80K
Sell10b5-1
2026-04-01
Bellon Christine
Chief Legal Officer
5,956 @ $24.58$146K
Sell10b5-1
2026-04-01
Simon Amy
Chief Medical Officer
6,700 @ $24.58$165K
Sell10b5-1
2026-04-01
Evans John M.
CEO
30,078 @ $24.58$739K
Grant
2026-03-31
Emany Sravan Kumar
Chief Financial Officer
31,750 @ ——
Grant
2026-03-31
Cavanagh Bethany J
SVP, Finance and Treasurer
20,000 @ ——
Grant
2026-03-31
Simon Amy
Chief Medical Officer
31,750 @ ——
Grant
2026-03-31
Ciaramella Giuseppe
President
40,000 @ ——
Exercise10b5-1
2026-03-31
Evans John M.
CEO
25,000 @ $0.67$17K
Sell10b5-1
2026-03-31
Evans John M.
CEO
25,000 @ $22.76$569K
Grant10b5-1
2026-03-31
Evans John M.
CEO
90,000 @ ——
Grant
2026-03-31
Bellon Christine
Chief Legal Officer
20,000 @ ——
Sell10b5-1
2026-03-30
Evans John M.
CEO
25,000 @ $22.37$559K
Exercise10b5-1
2026-03-30
Evans John M.
CEO
25,000 @ $0.67$17K
← All catalysts for $BEAM